中国医药(600056.SH)上半年净利润2.94亿元，同比下降16.19%

Core Viewpoint - China Medical (600056.SH) reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 17.076 billion yuan, a year-on-year decrease of 6.71% [1] - The net profit attributable to shareholders of the listed company was 294 million yuan, down 16.19% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 256 million yuan, reflecting an 11.05% year-on-year decline [1] - Basic earnings per share stood at 0.1965 yuan [1]